Anti-tumor necrosis factor α therapy in psoriatic arthritis and psoriasis

被引：0
|
作者：
Girolomoni, G [1 ]
Abeni, D [1 ]
机构：
[1] Ist Dermopat Immacolata, I-00167 Rome, Italy
来源：
ARCHIVES OF DERMATOLOGY | 2001年 / 137卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：784 / 785
页数：2
相关论文
共 50 条
  • [31] Breast Lymphoma Complicating Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis
    Pattanaik, Debendra
    Koduru, Swapna
    Azouz, Abdallah
    Patil, Sadanand
    Carbone, Laura
    CLINICAL BREAST CANCER, 2011, 11 (06) : 413 - 416
  • [32] GENDER DIFFERENCES IN RHEUMATOID ARTHRITIS: EFFECT OF ANTI-TUMOR NECROSIS FACTOR THERAPY
    Gioia, Chiara
    Spinelli, Francesca
    Priori, Roberta
    Iannuccelli, Cristina
    Lucchino, Bruno
    Vestri, Annarita
    Valesini, Guido
    DI Franco, Manuela
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1650 - 1650
  • [33] Graves' Disease, Rheumatoid Arthritis, and Anti-Tumor Necrosis Factor-α Therapy
    Shin, Jae Il
    Kim, Min Jung
    Lee, Jae Seung
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (02) : 449 - 450
  • [34] Genotoxicity of Anti-Tumor Necrosis Factor Therapy in Patients With Juvenile Idiopathic Arthritis
    Demirkaya, Erkan
    Cok, Ismet
    Durmaz, Emre
    Ulutas, Onur K.
    Ayaz, Nuray Aktay
    Besbas, Nesrin
    Ozen, Seza
    ARTHRITIS CARE & RESEARCH, 2010, 62 (01) : 73 - 77
  • [35] Erratum to: Anti-tumor necrosis factor-α therapy and changes of flow-mediated vasodilatation in psoriatic and rheumatoid arthritis patients
    Gianluigi Mazzoccoli
    Incoronata Notarsanto
    Gennaro Davide de Pinto
    Mariangela Pia Dagostino
    Angelo De Cata
    Giuseppe D’Alessandro
    Roberto Tarquini
    Gianluigi Vendemiale
    Internal and Emergency Medicine, 2011, 6 : 97 - 97
  • [36] Tumor Necrosis Factor Inhibitor Therapy and Myocardial Infarction Risk in Patients With Psoriasis, Psoriatic Arthritis, or Both
    Wu, Jashin J.
    Poon, Kwun-Yee T.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (08) : 932 - 934
  • [37] Tuberculosis infection versus anti-tumor necrosis factor therapy: screening challenges in psoriatic patients
    Solovan, Caius
    Chiticariu, Elena
    Timofte, Adelina
    Stoia-Djeska, Irina
    JOURNAL OF DRUG ASSESSMENT, 2012, 1 (01) : 65 - 67
  • [38] Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab
    Cauza, E
    Spak, M
    Cauza, K
    Hanusch-Enserer, U
    Dunky, A
    Wagner, E
    RHEUMATOLOGY INTERNATIONAL, 2002, 22 (06) : 227 - 232
  • [39] Treatment of psoriatic arthritis and psoriasis vulgaris with the tumor necrosis factor inhibitor infliximab
    Edmund Cauza
    Marita Spak
    Karla Cauza
    Ursula Hanusch-Enserer
    Attila Dunky
    Ernst Wagner
    Rheumatology International, 2002, 22 : 227 - 232
  • [40] Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis
    Ulfgren, AK
    Andersson, U
    Engström, M
    Klareskog, L
    Maini, RN
    Taylor, PC
    ARTHRITIS AND RHEUMATISM, 2000, 43 (11): : 2391 - 2396
12345